← Back to search
NEW YORK MEDICAL COLLEGE
VALHALLA, NY, 10595
Unclaimed
AI-Generated Company Overview
Generating overview from available records...
Source Records
No company-reported description yet. Owners can add one after claiming the profile.
Capabilities
Derived from government recordsGov-sourced
Prime contracting experience
1 record from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services Food and Drug Administration | TO CHARACTERIZE THE CLINICAL PRESENTATION OF C-VAM/TO CONTRAST C-VAM WITH CARDIAC COMPLICATIONS OF INFECTION WITH SARS-COV-2 THAT THE IMMUNIZATION SEEKS TO PREVENT/TO INFORM BEST PRACTICES FOR SURVEILLANCE AND MONITORING FOR C-VAM, INCLUDING IN ASYMP 75F40122C00148 | — | $2,573,556 | Sep 22, 2025 | Sep 26, 2022 – Sep 27, 2027 |
Contract vehicles are shown only when present in the source record.
Subcontracting experience
No subaward records on record in current sources. Subcontract relationships are never inferred from award keywords.
Agencies supported
- Department of Health and Human ServicesGov-sourced